Dual-Sequence PAC Plasmid for Biological Contaminant Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Biopharmaceutical manufacturing faces challenges in distinguishing between true positive and false positive results for biological contaminants due to cross-contamination during PCR testing, leading to costly corrective actions.
Innovation Solution
A positive amplification control (PAC) plasmid is introduced that includes a biological contaminant target sequence and a unique artificial plasmid-specific sequence, allowing real-time differentiation between true positives and false positives by monitoring the production of both sequences during PCR.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a positive amplification control is used in Q-PCR to detect biological contaminants, then the sensitivity and reliability of contaminant detection is improved, but the risk of false positive results due to cross-contamination increases
Solution Approach 1:
The positive amplification control plasmid is segmented into two distinct functional components: (1) a biological contaminant target sequence that enables detection of actual contaminants, and (2) a unique artificial plasmid-specific sequence that serves as a contamination marker. This segmentation allows the system to simultaneously detect both true positives and false positives by monitoring which sequence is amplified.
Solution Approach 2:
The unique artificial plasmid-specific sequence acts as an intermediary marker that indirectly indicates cross-contamination events. Instead of directly detecting contamination, the system uses this artificial sequence as a mediator - when it appears in the test sample, it signals that the positive control plasmid has contaminated the sample, thereby indicating a false positive result.
2Productivity
If Q-PCR is used to rapidly detect viral contaminants, then the detection speed is improved, but the occurrence of false positive results due to cross-contamination increases
Solution Approach 1:
The detection system segments the PCR assay into two parallel detection channels: one targeting the biological contaminant sequence and another targeting the artificial plasmid-specific sequence. This allows rapid simultaneous evaluation of both true contamination and false positive indicators without sacrificing detection speed.
Solution Approach 2:
The system incorporates real-time feedback by monitoring the amplification of the artificial plasmid-specific sequence during the Q-PCR process. When this sequence is detected, it provides immediate feedback that the result is a false positive, allowing the system to automatically flag or reject the contaminant detection result.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate identification of true positive PCR signals for biological contaminants, reducing the risk of false positives and minimizing unnecessary corrective actions.
Implementation Method 1
an oligonucleotide detection probe specific for the TAP sequence of the biological contaminant
Implementation Method 2
subjecting the reaction mixture to polymerase chain reaction (PCR)
Data Source
AI summary
Provided are compositions and methods useful to the determination of whether a microbial contaminant is present in a biological therapeutic production process. Specifically, an artificial positive amplification control plasmid and unique quantitative PCR detection probe are provided, which enables the rapid and real-time detection of a false positive result.